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Focus on. . .ubiquitin-related tumor suppressorsContinuing the previously published mini-review series on majority of malignant and metastatic breast cancers makes
ubiquitin-related tumor suppressors (TSs) [1–4], in this issue we
discuss functional aspects of the gene products of the von Hip-
pel-Lindau (VHL), Np95/ICB90-like RING ﬁnger (NIRF/UHRF2), Be-
clin 1 and RE-1 silencing transcription factor (REST) genes as
well as the role played in transcriptional regulation, mRNA pro-
cessing and DNA repair of histone H2B mono-ubiquitination
(H2Bub1).
Bader and Hsu [5] review what is known about the VHL TS gene
product, an E3 ubiquitin ligase that negatively regulates hypoxia-
induced factor (HIF). The a-subunit of HIF is a well-known target
of the VHL-containing E3 ligase that affects HIF-a poly-ubiquitina-
tion and degradation. Within the last years HIF has been shown to
function in the regulation of hematopoietic stem cells, innate and
adaptive immune cells and to affect glycolysis, apoptosis, cell pro-
liferation and differentiation of hematopoietic lineages. NIRF/
UHRF2 is a ubiquitin ligase that occupies a central position in the
cell cycle network by interacting with core cell cycle proteins
including cyclins A2, B1, D1 and E1, cyclin dependent kinases
CDK2, CDK4 and CDK6, retinoblastoma 1 protein RB1, tumor pro-
tein p53 and proliferating cell nuclear antigen (PCNA). Mori et al.
[6] very carefully describe the central role of NIRF/UHRF2 in the
cell cycle and informational cell network that distinguishes NIRF/
UHRF2 as an intermodular hub coordinating between the cell cycle
machinery, the ubiquitin–proteasome system and cell epigenetics.
As reviewed by Abrahamsen et al. [7], Beclin 1 is a multivalent
adaptor and TS protein that positively regulates the vacuolar sort-
ing protein (VPS) 34 the core component of the PI3K-III complex.
Although VPS34 activity is regulated by phosphorylation, the
PI3K-III complex is also controlled by ubiquitination of Beclin 1
or Beclin 1-associated components. Thus, the TS role of Beclin 1
seems to be directly connected to the activity of the PI3K-III com-
plex determining the cellular level of PtdIns3P, a key regulator of
autophagy, endocytosis and cytokinesis. H2B mono-ubiquitination
resulting in the synthesis of H2Bub1 plays a role both in transcrip-
tional activation and repression as well as in the control of mRNA
processing and DNA repair. Johnsen [8] provides a comprehensive
overview of the current understanding of mammalian H2Bub1
function related to changes in chromatin structure of rapidly in-
duced genes. Experimental evidence suggests that ubiquitination
of H2B and appropriate topology of the ubiquitin chain at the inter-
face between two adjacent nucleosomes facilitate disruption of
higher order chromatin structure thereby rapidly inducing gene
expression. Besides the high interest in the multiple nuclear
H2Bub1 activities, the fact that H2Bub1 is undetectable in the0014-5793/$36.00  2012 Federation of European Biochemical Societies. Published by E
http://dx.doi.org/10.1016/j.febslet.2012.05.001H2Bub1 a particularly interesting target for breast cancer therapy.
In the last contribution of this series Huang and Bao [9] discuss the
RE-1 silencing transcription factor (REST) that functions as a mas-
ter transcriptional repressor with critical role in neural-speciﬁc
gene expression. The REST protein level is reduced by b-TrCP-med-
iated ubiquitination critically determining cell fate of neural stem
or progenitor cells. During astrocyte differentiation from neural
progenitor cells bone morphogenic protein maintains REST levels
thereby repressing neural gene expression. However, comparative
studies on epithelial cancers and brain tumors showed that while
REST in epithelial cells acts as a TS, in brain tumors it clearly exerts
an oncogenic role.
Although all TSs or candidate TSs discussed in this mini-review
series relate to the ubiquitin system, the mechanistic aspects of
how ubiquitination is implicated in TS functions are rather diver-
gent and thus within TS signaling cascades multiple targets exist
that might be utilized for speciﬁc and promising cancer therapy.
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